Statistics for RAPT Therapeutics (id:6510 RAPT)

Valuation metrics

Market cap

37.75M

Enterprise value

-56,078,836.00

Trailing P/E (ttm)

-0.35

Forward P/E

-0.57

PEG ratio

-0.57

Price/Sales (ttm)

Price/Book (mrq)

0.39

Enterprise Value/Revenue

Enterprise Value/EBITDA

0.49

Overview

Shares outstanding

34.96M

Float

31.60M

Shares short

2.67M

% Held by insiders

0.02%

% Held by institutions

0.87%

Average volume (10 days)

1.72M

Average volume (90 days)

Price summary

52-Week low

1.00

52-Week high

27.35

52-Week change

-1,185.18%

Beta

0.32

50-Day moving average

1.86

200-Day moving average

5.10

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-46.58%

Return on equity

-80.13%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-113,614,000.00

Net income to common (ttm)

-107,492,000.00

Diluted EPS (ttm)

-2.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

97.90M

Total cash per share (mrq)

2.80

Total debt (mrq)

5.12M

Total Debt/Equity (mrq)

5.36

Current ratio (mrq)

990.10%

Book value per share (mrq)

2.74

Cash flow

Cash flow statement

-100,614,000.00

Levered free cash flow (LFCF)

-64,909,124.00